![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Multiple Sclerosis |
|
Free Subscription
1 BMC Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Multiple Sclerosis is free of charge.
The influence of adolescent diet on the occurrence of late-onset multiple
sclerosis: a population-based case-control study.
BMC Neurol. 2026 May 2. doi: 10.1186/s12883-026-04919.
PubMed
Abstract available
Smoked nicotine use is associated with depressive symptoms in women with multiple
sclerosis.
Can J Neurol Sci. 2026 May 7:1-9. doi: 10.1017/cjn.2026.10617.
PubMed
MicroRNA profiles in multiple sclerosis: A review of the literature.
J Neuroimmunol. 2026;417:578946.
PubMed
Abstract available
The practice effect of smartphone-derived cognitive processing speed assessments
as a proxy of cognitive functioning in multiple sclerosis.
J Neurol. 2026;273:305.
PubMed
Abstract available
Refining neuropsychological assessment strategies in multiple sclerosis: insights
from long-term cognitive trajectories.
J Neurol. 2026;273:304.
PubMed
Abstract available
Autologous haematopoietic stem cell transplantation in multiple sclerosis:
outcomes and predictors from German real-world data.
J Neurol Neurosurg Psychiatry. 2026 May 6:jnnp-2025-338129.
PubMed
Abstract available
Methodological considerations in evaluating lifetime estrogen exposure and
neurodegeneration in multiple sclerosis.
J Neurol Sci. 2026;486:125963.
PubMed
No interferon-beta antibodies in natalizumab-treated multiple sclerosis patients
with progressive multifocal leukoencephalopathy.
J Neurol Sci. 2026;486:125947.
PubMed
Abstract available
Kappa free light chain index or oligoclonal bands testing in clinical practice
for multiple sclerosis diagnosis: An algorithm comparative study.
Mult Scler. 2026 May 6:13524585261442020. doi: 10.1177/13524585261442020.
PubMed
Abstract available
Differences in Use of Disease-Modifying Therapies Between Patients With
Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Neurology. 2026;106:e214943.
PubMed
Abstract available
Early Human Intrathecal Mesenchymal Stem Cell Study in Progressive Multiple
Sclerosis Faces Delivery Challenges.
Neurology. 2026;106:e214955.
PubMed
Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A
Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).
Neurology. 2026;106:e214915.
PubMed
Abstract available
Thank you for your interest in scientific medicine.